B2M and COVID-19: Among the significantly up- or down-regulated proteins in COVID-19 patient urine, metallothionein-1G, lipoprotein lipase, β2M, PRKACA, FOLR2, and APOA4, showed significant changes compared to both healthy controls and non-COVID-19 pneumonia cases (Fig. 2c).